Myocardial fibrosis predicts adverse outcome after MitraClip implantation

Juliëtte F Velu1, Alexander Hirsch2, S M Boekholdt1

  • 1Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Heart Center, University of Amsterdam, Amsterdam, The Netherlands.

Abstract

Insights

Myocardial fibrosis, detected via cardiovascular magnetic resonance, predicts adverse outcomes in high-risk mitral regurgitation patients receiving the MitraClip device. This finding may aid clinical decision-making for these complex cases.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Interventional Cardiology

Background:

  • High-risk patients with mitral regurgitation (MR) often undergo percutaneous mitral valve repair using the MitraClip.
  • Identifying which patients will benefit from MitraClip implantation remains challenging.

Purpose of the Study:

  • To investigate if myocardial fibrosis predicts outcomes in MR patients treated with MitraClip.
  • To assess the utility of myocardial fibrosis detection in clinical decision-making for MitraClip procedures.

Main Methods:

  • Preprocedural cardiovascular magnetic resonance (CMR) with late gadolinium enhancement was used to analyze myocardial fibrosis.
  • Adverse outcome was defined as New York Heart Association (NYHA) class III-IV or death within one month post-MitraClip implantation.

Main Results:

  • Myocardial fibrosis was identified in a significant proportion of patients (55% degenerative MR, 64% functional MR).
  • Patients with myocardial fibrosis had a substantially higher rate of adverse outcomes (69%) compared to those without (11%, P=0.01).

Conclusions:

  • The presence of myocardial fibrosis is a predictor of adverse outcomes in patients undergoing MitraClip implantation for MR.
  • Further studies with larger sample sizes are needed to confirm these findings and integrate myocardial fibrosis assessment into clinical decision-making and prognosis evaluation.

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.8K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.8K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.2K
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
802
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
871